ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (49)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christenson, B.
Right arrow Articles by Örtqvist, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christenson, B.
Right arrow Articles by Örtqvist, A.
Eur Respir J 2004; 23:363-368
Copyright ©ERS Journals Ltd 2004


Additive preventive effect of influenza and pneumococcal vaccines in elderly persons

B. Christenson1, J. Hedlund2, P. Lundbergh1 and Å. Örtqvist1,2

1 Dept of Communicable Disease Control and Prevention, Stockholm County, and 2 Dept of Infectious Diseases, Karolinska Institutet, Karolinska Hospital, S-171 76, Stockholm, Sweden

CORRESPONDENCE: Å. Örtqvist, Dept of Communicable Diseases and Prevention, Norrbacka, Karolinska Hospital, SE-171 76, Stockholm, Sweden. Fax: 46 8315767. E-mail: ake.ortqvist@sme.sll.se

Keywords: elderly, influenza vaccine, pneumococcal vaccine

Received: June 5, 2003
Accepted September 16, 2003

This study was supported financially by Stockholm City Council, The Swedish Heart-Lung Foundation, and Karolinska Institutet.

In 1999, all individuals ≥65 yrs of age (n=258,754) in Stockholm County, Sweden, were offered influenza and pneumococcal vaccination in a prospective study on the effectiveness of these vaccines in reducing the need for hospital treatment and death due to influenza, pneumonia and invasive pneumococcal disease (IPD). Data on hospitalisation and mortality during 1 yr were obtained from the administrative database in Stockholm County Council.

Vaccination was performed in 124,702 (48%) subjects; 72,107 had both vaccines, 29,346 only had the influenza vaccine and 23,249 only had the pneumococcal vaccine. Compared with the unvaccinated cohort, a lower incidence of hospitalisation for all end-point diagnoses was seen in vaccinated persons.

An additive effectiveness of vaccination was seen when both vaccines were given, with a reduction of hospital admissions for influenza (37%), pneumonia (29%) and IPD (44%). In-hospital mortality for pneumonia was significantly lower in those who received both vaccines, than in unvaccinated persons.

To conclude, vaccination with influenza and pneumococcal vaccines together was effective in reducing the need for hospital admission for influenza and pneumonia. There was a strong indication that pneumococcal vaccination alone, was effective not only in the prevention of invasive pneumococcal disease, but also of pneumonia overall, although to a low degree.




This article has been cited by other articles:


Home page
J. Epidemiol. Community HealthHome page
J H S You, W C W Wong, M Ip, N L S Lee, and S C Ho
Cost-effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilities
J Epidemiol Community Health, November 1, 2009; 63(11): 906 - 911.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A Sliedrecht, W P J den Elzen, T J M Verheij, R G J Westendorp, and J Gussekloo
Incidence and predictive factors of lower respiratory tract infections among the very elderly in the general population. The Leiden 85-plus Study
Thorax, September 1, 2008; 63(9): 817 - 822.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. Johnstone, T. J. Marrie, D. T. Eurich, and S. R. Majumdar
Effect of Pneumococcal Vaccination in Hospitalized Adults With Community-Acquired Pneumonia
Arch Intern Med, October 8, 2007; 167(18): 1938 - 1943.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. C. Kapetanovic, T. Saxne, J.-A. Nilsson, and P. Geborek
Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients
Rheumatology, April 1, 2007; 46(4): 608 - 611.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
T. M. File Jr and J. S. Tan
Pneumonia in Older Adults: Reversing the Trend
JAMA, December 7, 2005; 294(21): 2760 - 2763.
[Full Text] [PDF]


Home page
Eur Respir JHome page
A. de Roux and H. Lode
Pneumococcal vaccination
Eur. Respir. J., December 1, 2005; 26(6): 982 - 983.
[Full Text] [PDF]


Home page
Eur Respir JHome page
A. Vila-Corcoles, O. Ochoa-Gondar, C. Llor, I. Hospital, T. Rodriguez, and A. Gomez
Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects
Eur. Respir. J., December 1, 2005; 26(6): 1086 - 1091.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Shi, T. Yamazaki, Y. Okubo, Y. Uehara, K. Sugane, and K. Agematsu
Regulation of Aged Humoral Immune Defense against Pneumococcal Bacteria by IgM Memory B Cell
J. Immunol., September 1, 2005; 175(5): 3262 - 3267.
[Abstract] [Full Text] [PDF]


Home page
JWatch Infect. DiseasesHome page
Combined Influenza and Pneumococcal Vaccination: A Success Story
Journal Watch Infectious Diseases, March 29, 2004; 2004(329): 4 - 4.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the European Respiratory Society.